Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuhiro Oki

Showing results (11-20 of 164) with videos related to

Pageof 17
Sort By:
British Journal of Haematology|December 17, 2013
Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? - Response to Landsburg et alJason Westin, Yasuhiro Oki, Luis Fayad
The New Zealand Medical Journal|November 15, 2003
A case of QT-interval prolongation precipitated by azithromycinNaohisa Matsunaga, Yasuhiro Oki, Alejandro Prigollini
Cancer Treatment and Research|March 23, 2010
Epigenetic mechanisms in AML - a target for therapyYasuhiro Oki, Jean-Pierre J Issa
Expert Review of Hematology|June 15, 2011
Clinical development of panobinostat in classical Hodgkin's lymphomaYasuhiro Oki, Amanda Copeland, Anas Younes
Dermatology Online Journal|March 23, 2017
Atypical lymphoproliferative disorder-clinical and pathological featuresKelly Wilmas, Madeleine Duvic, Yasuhiro Oki
Reviews on Recent Clinical Trials|May 14, 2008
Review: recent clinical trials in epigenetic therapyYasuhiro Oki, Jean-Pierre J Issa
International Journal of Hematology|December 7, 2007
Treatment options in advanced myelodysplastic syndrome, with emphasis on epigenetic therapyYasuhiro Oki, Jean-Pierre J Issa
Angewandte Chemie (International Ed. in English)|April 29, 2018
Lipase-Catalyzed Dynamic Kinetic Resolution of C<sub>1</sub> - and C<sub>2</sub> -Symmetric Racemic Axially Chiral 2,2'-Dihydroxy-1,1'-biarylsGamal A I Moustafa, Yasuhiro Oki, Shuji Akai
Critical Reviews in Oncology/Hematology|October 7, 2006
Decitabine--bedside to benchYasuhiro Oki, Etsuko Aoki, Jean-Pierre J Issa
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Novel treatments for T-cell lymphomaChan Yoon Cheah, Yasuhiro Oki, Michelle A Fanale
Pageof 17

Showing results (11-20 of 164) with videos related to

Sort By:
Pageof 17
British Journal of Haematology|December 17, 2013
Could treatment with R-HCVAD/R-MA as compared to R- CHOP truly result in improved outcomes for patients with high-risk diffuse large B cell lymphoma? - Response to Landsburg et alJason Westin, Yasuhiro Oki, Luis Fayad
The New Zealand Medical Journal|November 15, 2003
A case of QT-interval prolongation precipitated by azithromycinNaohisa Matsunaga, Yasuhiro Oki, Alejandro Prigollini
Cancer Treatment and Research|March 23, 2010
Epigenetic mechanisms in AML - a target for therapyYasuhiro Oki, Jean-Pierre J Issa
Expert Review of Hematology|June 15, 2011
Clinical development of panobinostat in classical Hodgkin's lymphomaYasuhiro Oki, Amanda Copeland, Anas Younes
Dermatology Online Journal|March 23, 2017
Atypical lymphoproliferative disorder-clinical and pathological featuresKelly Wilmas, Madeleine Duvic, Yasuhiro Oki
Reviews on Recent Clinical Trials|May 14, 2008
Review: recent clinical trials in epigenetic therapyYasuhiro Oki, Jean-Pierre J Issa
International Journal of Hematology|December 7, 2007
Treatment options in advanced myelodysplastic syndrome, with emphasis on epigenetic therapyYasuhiro Oki, Jean-Pierre J Issa
Angewandte Chemie (International Ed. in English)|April 29, 2018
Lipase-Catalyzed Dynamic Kinetic Resolution of C<sub>1</sub> - and C<sub>2</sub> -Symmetric Racemic Axially Chiral 2,2'-Dihydroxy-1,1'-biarylsGamal A I Moustafa, Yasuhiro Oki, Shuji Akai
Critical Reviews in Oncology/Hematology|October 7, 2006
Decitabine--bedside to benchYasuhiro Oki, Etsuko Aoki, Jean-Pierre J Issa
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Novel treatments for T-cell lymphomaChan Yoon Cheah, Yasuhiro Oki, Michelle A Fanale
Pageof 17